论文部分内容阅读
目的探讨我国药品价值链的初步形成机制。方法查阅相关文献、调查现行药品流通过程,分析我国药品价格形成因素和影响药品价格形成机制的各种因素。结果在药品价格体系中,药品价格形成机制主要表现为2个方面,即政府部门的管制定价与市场自由定价。我国药品流通环节复杂,在每个流通环节各级经销商都会提高药品价格来获取利润,同时药品利益牵涉面众多,医药企业数量多、规模小,市场集中度低,进入壁垒低,形成以药养医的体制;过多的流通环节,对于药品质量、价格管控均不利。结论应提高医药企业的技术实力与规模,设立严格的市场准入制度,优化流通环节,改革以药养医的医疗关系体制,从而有效降低药价虚高、减轻患者负担。
Objective To explore the initial formation mechanism of Chinese medicine value chain. Methods Consult the relevant literature, investigate the current drug circulation process, analyze the factors that influence the formation of drug prices and the factors that affect the formation of drug prices. Results In the drug price system, the drug price formation mechanism mainly manifested in two aspects, that is, the regulatory pricing of government departments and the market free pricing. Drug circulation in our country is complicated. Distributors at all levels in every circulation link will increase the price of medicines to obtain profits. At the same time, there are many pharmaceutical interests involved. The number of pharmaceutical enterprises is small, the market is low, the barriers to entry are low, Support the medical system; excessive circulation links, for the quality of medicines, price control are adverse. Conclusion The technical strength and scale of pharmaceutical enterprises should be improved. A strict market access system should be established to optimize the circulation and reform of the medical relationship system based on medicine and medicine so as to effectively reduce the price of drugs and reduce the burden on patients.